Last updated: June 17, 2026
DIANEAL 137 W/ DEXTROSE 4.25% Suppliers: Who Manufactures and Supplies This CAPD/Dialysis Solution in Plastic Containers?
DIANEAL 137 W/ Dextrose 4.25% in plastic container is a Baxter-manufactured peritoneal dialysis (PD) solution under the DIANEAL brand. Baxter is the known commercial source and supplier for the marketed product in the US, including plastic-container presentations.
Who supplies DIANEAL 137 W/ Dextrose 4.25% in plastic containers?
Primary supplier (brand holder/manufacturer): Baxter.
- DIANEAL 137 W/ Dextrose 4.25% is marketed as a Baxter PD fluid for continuous ambulatory peritoneal dialysis (CAPD) and is supplied under the DIANEAL brand.
What is the role of the US distributor vs. the manufacturer?
- In distribution, wholesalers and pharmacy supply chains may appear as “suppliers” on invoices and procurement feeds, but the product’s manufacturing and regulatory ownership for DIANEAL is tied to Baxter as the marketing authorization holder/manufacturer for the branded product in standard US labeling.
Is DIANEAL 137 W/ Dextrose 4.25% only supplied by Baxter?
In the marketed branded channel, DIANEAL is supplied by Baxter.
- Direct “alternate manufacturer” supply is generally limited for the exact branded configuration.
- The practical route to competition is typically generic/authorized alternatives rather than multiple brand-source manufacturers, because PD solutions are commodity-like but tightly controlled through controlled formulations, stability, packaging format, and regulatory listings.
What alternative products could replace it without changing the therapeutic class?
- Substitution typically occurs by choosing a different PD solution composition (different dextrose strength, buffer system, or osmolarity) or a different brand/generic equivalent listed for the same intended use.
- Any substitution depends on Orange Book/ANDA status for exact equivalents and on institutional formulary approvals.
What generic or authorized equivalent risk exists for DIANEAL 137 W/ Dextrose 4.25%?
The supplier landscape is usually determined by whether FDA lists an approved equivalent (generic or authorized).
- If an approved equivalent exists for the exact strength and container type, procurement may shift from Baxter to that approved source.
What to check in FDA databases to identify non-Baxter suppliers
- FDA’s Orange Book and the Drug Product Database (for application holders and listed products) identify whether an ANDA exists for an equivalent PD solution strength and presentation.
- Without those database specifics, procurement “suppliers” can be misleading because distributors change while the application holder and manufacturer typically remain consistent.
Which plastic container suppliers matter for PD solutions?
For PD fluids, “container supplier” is often an upstream manufacturing component, while the labeled product remains Baxter-branded.
What procurement usually targets in plastic-container PD fluids
- The key procurement levers are:
- the exact labeled formulation (137 W, dextrose 4.25%)
- the container configuration (plastic container format)
- the regulatory application holder/manufacturer
- distribution availability and lot release continuity
How do you identify true alternative suppliers for DIANEAL 137 W/ Dextrose 4.25% procurement?
Procurement teams typically classify supply sources into:
- Application holder/manufacturer for the listed drug product (regulatory responsibility)
- Wholesale distributor (logistics and inventory)
- Contract manufacturing/packaging partners (often not visible on label)
What documentation is used in buying decisions
- FDA listing data (application holder and manufacturer)
- lot-specific release documentation
- distributor product codes tied to the labeled product strength and container type
Commercial and supply-chain considerations
Availability drivers for PD solutions
- Sterile manufacturing capacity
- container packaging supply continuity
- regulatory release and batch quality controls
- cold chain usually is not the central constraint for standard PD solutions, but shelf-life and stability are core planning factors.
Key Takeaways
- Baxter is the primary supplier/manufacturer for DIANEAL 137 W/ Dextrose 4.25% in plastic containers in the branded market.
- “Suppliers” shown in procurement systems may reflect distributors, not alternative manufacturers.
- Identifying non-Baxter supply requires checking FDA drug listing records for application holders/manufacturers tied to the same labeled strength and container presentation.
FAQs
-
Are there non-Baxter manufacturers for DIANEAL 137 W/ Dextrose 4.25% plastic containers in the US?
Brand DIANEAL is supplied by Baxter; non-Baxter sources typically arise only via FDA-approved equivalents.
-
Do wholesale distributors change the drug’s manufacturer for DIANEAL?
No. Distributors change inventory and logistics, while the product’s regulated application holder/manufacturer remains tied to Baxter.
-
What exact label attributes must match to substitute DIANEAL 137 W/ Dextrose 4.25%?
The solution composition (137 W, dextrose 4.25%) and the presentation/container format.
-
Where can procurement teams confirm the manufacturer behind the DIANEAL SKU?
FDA drug product listing records and lot documentation linked to the labeled product.
-
What is the fastest way to evaluate supply continuity risk for PD fluids like DIANEAL?
Track historical allocations, lot release timing, and distributor lead times for the exact strength and container presentation.
References
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration.
- FDA. Drug Products (Drugs@FDA and related databases). U.S. Food and Drug Administration.
